Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Am J Clin Pathol

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    June 2021
  1. ASIRVATHAM JR, Jorns JM
    How Do Pathologists in Academic Institutions Across the United States and Canada Evaluate Sentinel Lymph Nodes in Breast Cancer?
    Am J Clin Pathol. 2021 Jun 24. pii: 6308671. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  2. MUGABE M, Ho KE, Ruhangaza D, Milner D, et al
    Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country.
    Am J Clin Pathol. 2021 May 29. pii: 6288023. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  3. POLONIA A, Campelos S, Ribeiro A, Aymore I, et al
    Artificial Intelligence Improves the Accuracy in Histologic Classification of Breast Lesions.
    Am J Clin Pathol. 2021;155:527-536.
    PubMed     Abstract available


    October 2020
  4. VAN BOCKSTAL MR, Berliere M, Duhoux FP, Galant C, et al
    Interobserver Variability in Ductal Carcinoma In Situ of the Breast.
    Am J Clin Pathol. 2020;154:596-609.
    PubMed     Abstract available


    April 2020
  5. ZHANG H, Moisini I, Ajabnoor RM, Turner BM, et al
    Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the Breast.
    Am J Clin Pathol. 2020;153:583-592.
    PubMed     Abstract available


    February 2020
  6. ALGHAMDI SA, Krishnamurthy K, Garces Narvaez SA, Algashaamy KJ, et al
    Low-Grade Ductal Carcinoma In Situ.
    Am J Clin Pathol. 2020;153:360-367.
    PubMed     Abstract available


    January 2020
  7. BULTE JP, Halilovic A, Burgers LJM, Diepenbroek CJM, et al
    Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens.
    Am J Clin Pathol. 2020;153:58-65.
    PubMed     Abstract available


    June 2019
  8. LIN L, Sirohi D, Coleman JF, Gulbahce HE, et al
    American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory.
    Am J Clin Pathol. 2019 Jun 7. pii: 5512208. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  9. MULLER KE, Marotti JD, Tafe LJ
    Pathologic Features and Clinical Implications of Breast Cancer With HER2 Intratumoral Genetic Heterogeneity.
    Am J Clin Pathol. 2019 Mar 20. pii: 5398564. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  10. SCHNEIDER F, Jin Y, Van Smaalen K, Gulbahce EH, et al
    The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers.
    Am J Clin Pathol. 2019 Jan 21. pii: 5298369. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  11. KHOURY T, Peng X, Yan L, Wang D, et al
    Tumor-Infiltrating Lymphocytes in Breast Cancer: Evaluating Interobserver Variability, Heterogeneity, and Fidelity of Scoring Core Biopsies.
    Am J Clin Pathol. 2018 Jul 25. pii: 5059056. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  12. LANDMANN A, Farrugia DJ, Zhu L, Diego EJ, et al
    Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Am J Clin Pathol. 2018 May 8. pii: 4993844. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  13. CLARK BZ, Farrugia DJ, Landmann A, Diego EJ, et al
    Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.
    Am J Clin Pathol. 2018 Feb 22. pii: 4899077. doi: 10.1093.
    PubMed     Abstract available


  14. KHOURY T
    Delay to Formalin Fixation (Cold Ischemia Time) Effect on Breast Cancer Molecules.
    Am J Clin Pathol. 2018 Feb 19. pii: 4874188. doi: 10.1093.
    PubMed     Abstract available


    November 2017
  15. SHIN ET, Joehlin-Price AS, Agnese DM, Zynger DL, et al
    Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ: An Opportunity for Improved Resource Utilization.
    Am J Clin Pathol. 2017;148:374-379.
    PubMed     Abstract available


    October 2017
  16. GULBAHCE HE
    Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference Laboratory.
    Am J Clin Pathol. 2017;148:308-313.
    PubMed     Abstract available


    August 2017
  17. KHOURY T, Zirpoli G, Cohen SM, Geradts J, et al
    Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.
    Am J Clin Pathol. 2017;148:108-118.
    PubMed     Abstract available


  18. HOU Y, Zynger DL, Li X, Li Z, et al
    Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast.
    Am J Clin Pathol. 2017;148:167-172.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: